HOUSTON (Sept. 15, 2015) – The University of Texas MD Anderson Cancer Center has embarked on plans to develop and build a new $113.75 million outpatient diagnostic and treatment center in Central Park, a Wolff Companies development.
Planned for groundbreaking in 2016 and an opening in 2018, the new 175,000 square-foot facility will be MD Anderson’s first free-standing clinical building constructed outside Houston’s Texas Medical Center. The new center represents the first phase of a long-term plan by MD Anderson to develop facilities on its 34.5-acre campus in Central Park, located near the intersection of Interstate 10 and North Dairy Ashford.
“MD Anderson Cancer Center is among a handful of elite healthcare institutions in the United States, and we’re elated that our Central Park location is ideal for their strategy to better serve the fast-growing West Houston metro area,” said David S. Wolff, Chairman and President of Wolff Companies. “MD Anderson’s announcement comes on the heels of recently announced expansion plans for Texas Children’s Hospital West Campus and Methodist West Houston Hospital. All three major developments are driving demand for new residential, senior living and medical facilities that benefit from their strategic proximity to these healthcare providers.”
“It’s great to get the green light from the Board of Regents to start work on a new facility that will give the residents of West Houston and the surrounding region even greater access to MD Anderson specialty services, care, research and diagnostics,” said Thomas Burke, M.D., executive vice president, MD Anderson Cancer Network®. “Our mission to end cancer charges us with expanding and adapting programs that best reflect and respond to the needs of our patients, and this new center demonstrates that commitment.”
Assembled by Wolff Companies in late 2011 and early 2012, Central Park is centrally located in The Corridor midway between Loop 610 and the Grand Parkway, with easy accessibility from all areas of greater West Houston via I-10 and the I-10 HOV/Toll lanes, which flow directly to the property. As part of MD Anderson’s plan to develop and establish a more strategic and long-term approach to its cancer treatment operations in West Houston, the institution considered several sites, ultimately purchasing the site for its campus in Central Park in late 2012 due to its location, size, visibility and access.
“Central Park also offers buyers one of the most protected environments in the region due to its adjacency to 14,000 acres of Addicks/Cullen Park to the north and the extension of Terry Hershey Park to the east, as well as our carefully crafted protective covenants,” said Wolff.